What is the CVSS score of CVE-2024-9832?

CVE-2024-9832 has a CVSS 3.1 base score of 9.3 (Critical). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H. EPSS exploitation probability: 0.2%.

There CVE-2024-9832

CRITICAL

Improper Restriction of Excessive Authentication Attempts (CWE-307)

2024-11-14 productsecurity@baxter.com

Authentication Bypass Information Disclosure

9.3

CVSS 3.1 · Vendor: baxter

Severity by source

Vendor (baxter) PRIMARY

9.3 CRITICAL

AV:L/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Primary rating from Vendor (baxter) · only source for this CVE.

CVSS VectorVendor: baxter

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Changed

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Nov 14, 2024 - 21:15 cve.org

CRITICAL 9.3

DescriptionCVE.org

There is no limit on the number of failed login attempts permitted with the Clinician Password or the Serial Number Clinician Password. An attacker could execute a brute-force attack to gain unauthorized access to the ventilator, and then make changes to device settings that could disrupt the function of the device and/or result in unauthorized information disclosure.

AnalysisAI

There is no limit on the number of failed login attempts permitted with the Clinician Password or the Serial Number Clinician Password. Rated critical severity (CVSS 9.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-307. There is no limit on the number of failed login attempts permitted with the Clinician Password or the Serial Number Clinician Password. An attacker could execute a brute-force attack to gain unauthorized access to the ventilator, and then make changes to device settings that could disrupt the function of the device and/or result in unauthorized information disclosure.

Affected ProductsAI

See vendor advisory for affected versions.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.